- Home
- ENSC vs XPON Comparison
ENSC vs XPON Comparison
Compare ENSC & XPON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- XPON
- Stock Information
- Founded
- ENSC 2003
- XPON 2016
- Country
- ENSC United States
- XPON United States
- Employees
- ENSC N/A
- XPON N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- XPON Electronic Components
- Sector
- ENSC Health Care
- XPON Technology
- Exchange
- ENSC Nasdaq
- XPON Nasdaq
- Market Cap
- ENSC 2.9M
- XPON 2.7M
- IPO Year
- ENSC N/A
- XPON 2022
- Fundamental
- Price
- ENSC $3.29
- XPON $0.95
- Analyst Decision
- ENSC
- XPON
- Analyst Count
- ENSC 0
- XPON 0
- Target Price
- ENSC N/A
- XPON N/A
- AVG Volume (30 Days)
- ENSC 4.9M
- XPON 45.6K
- Earning Date
- ENSC 05-12-2025
- XPON 05-13-2025
- Dividend Yield
- ENSC N/A
- XPON N/A
- EPS Growth
- ENSC N/A
- XPON N/A
- EPS
- ENSC N/A
- XPON N/A
- Revenue
- ENSC $5,210,031.00
- XPON $5,624,939.00
- Revenue This Year
- ENSC N/A
- XPON $61.26
- Revenue Next Year
- ENSC N/A
- XPON N/A
- P/E Ratio
- ENSC N/A
- XPON N/A
- Revenue Growth
- ENSC 133.58
- XPON N/A
- 52 Week Low
- ENSC $1.62
- XPON $0.67
- 52 Week High
- ENSC $14.67
- XPON $236.00
- Technical
- Relative Strength Index (RSI)
- ENSC 55.92
- XPON 53.14
- Support Level
- ENSC $3.02
- XPON $0.74
- Resistance Level
- ENSC $4.85
- XPON $0.91
- Average True Range (ATR)
- ENSC 0.40
- XPON 0.08
- MACD
- ENSC 0.27
- XPON 0.03
- Stochastic Oscillator
- ENSC 51.70
- XPON 86.25
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.